StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
11
This month
1
This year
2
Publishing Date
2024 - 04 - 17
1
2024 - 02 - 27
1
2023 - 08 - 02
1
2023 - 05 - 03
1
2022 - 11 - 03
1
2022 - 09 - 14
1
2022 - 07 - 07
1
2022 - 06 - 09
1
2022 - 03 - 01
1
2022 - 02 - 14
1
2021 - 11 - 02
1
Sector
Consumer non-durables
1
Health technology
11
Tags
Biocapital
1
Dna
1
Earnings
2
Financial
4
Financial results
2
Global
2
Macular
3
Market
3
N/a
7
People
1
Report
2
Research
1
Results
6
Treatment
3
Year
1
Entities
3m company
8
Abbott laboratories
106
Abbvie inc.
218
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
12
Alcon inc.
14
Alkermes plc
7
Amgen inc.
168
Astellas pharma inc
70
Astrazeneca plc
172
Autolus therapeutics plc
7
Bausch health companies inc.
61
Baxter international inc.
45
Becton, dickinson and company
17
Beigene, ltd.
7
Biogen inc.
47
Biomarin pharmaceutical inc.
6
Biontech se
9
Boston scientific corporation
13
Brainstorm cell therapeutics inc.
8
Bristol-myers squibb company
82
Chinook therapeutics, inc.
7
Csl ltd
9
Danaher corporation
10
Eli lilly and company
121
Endo international plc
20
General electric company
8
Genmab a/s
12
Gilead sciences, inc.
25
Glaxosmithkline plc
265
Grifols sa
10
Incyte corporation
15
Ionis pharmaceuticals, inc.
7
Jazz pharmaceuticals plc
13
Johnson & johnson
189
Koninklijke philips n.v.
17
Mallinckrodt plc
17
Medtronic plc
29
Morphosys ag
13
Novartis ag
1035
Novo nordisk a/s
27
Orange
8
Orchard therapeutics plc
8
Perrigo company
7
Pfizer, inc.
68
Precision biosciences, inc.
8
Reckitt benckiser group plc
10
Regeneron pharmaceuticals, inc.
12
Regenxbio inc.
11
Sanofi
285
Smith & nephew plc
7
Stryker corporation
10
Takeda pharmaceutical company limited
51
Terumo corp
9
Teva pharmaceutical industries limited
9
Teva pharmaceutical industries ltd
206
Thermo fisher scientific inc
48
Ucb s.a.
8
Viatris inc.
115
Xencor, inc.
9
Symbols
ABBV
1
ABEO
3
ADAP
2
ADVM
1
AGIO
1
AGTC
3
ALNY
2
APTX
1
BDX
1
BEAM
1
BHC
4
BIIB
1
BLUE
2
CLSD
16
CRSP
2
DNLI
2
EDIT
3
EYEN
1
FNCTF
1
GILD
2
GLAXF
1
GSK
1
KOD
1
LLY
2
LZAGF
1
LZAGY
1
MO
1
MS
3
NTLA
2
NVS
12
NVSEF
11
OPT
1
ORTX
3
PFE
1
QURE
7
RARE
5
RCKT
2
RGNX
132
SEEL
1
SGMO
2
SLDB
3
SNY
5
SNYNF
5
SRPT
5
TAK
1
TMO
3
VRTX
1
Exchanges
Nasdaq
11
Nyse
11
Crawled Date
2024 - 04 - 17
1
2024 - 02 - 27
1
2023 - 08 - 02
1
2023 - 05 - 04
1
2022 - 11 - 03
1
2022 - 09 - 14
1
2022 - 07 - 07
1
2022 - 06 - 09
1
2022 - 03 - 01
1
2022 - 02 - 14
1
2021 - 11 - 02
1
Crawled Time
00:00
1
09:00
1
10:00
2
12:20
1
16:00
1
18:00
1
20:00
2
21:00
1
22:00
1
Source
www.biospace.com
4
www.prnewswire.com
7
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Regenxbio inc.
symbols :
NVSEF
save search
Viral Vector and Plasmid DNA Technologies: A Global Market Perspective
Published:
2024-04-17
(Crawled : 10:00)
- prnewswire.com
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
|
3.61%
|
O:
-0.26%
H:
0.03%
C:
-1.55%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
5.96%
|
O:
0.87%
H:
0.16%
C:
-0.59%
RGNX
|
$16.05
0.94%
0.93%
350K
|
Health Technology
|
-10.11%
|
O:
-1.43%
H:
2.27%
C:
-3.18%
global
dna
market
REGENXBIO Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
Published:
2024-02-27
(Crawled : 21:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-4.65%
|
O:
0.05%
H:
0.06%
C:
-0.95%
RGNX
|
$16.05
0.94%
0.93%
350K
|
Health Technology
|
-19.88%
|
O:
-5.04%
H:
5.42%
C:
4.68%
year
financial
results
REGENXBIO Reports Second Quarter 2023 Financial Results and Recent Operational Highlights
Published:
2023-08-02
(Crawled : 20:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-4.28%
|
O:
-1.38%
H:
0.77%
C:
0.7%
RARE
F
|
$44.26
-1.88%
-1.92%
670K
|
Health Technology
|
4.56%
|
O:
0.0%
H:
0.85%
C:
-2.48%
RGNX
|
$16.05
0.94%
0.93%
350K
|
Health Technology
|
-15.13%
|
O:
-7.2%
H:
10.26%
C:
-0.34%
financial
results
REGENXBIO Reports First Quarter 2023 Financial Results and Recent Operational Highlights
Published:
2023-05-03
(Crawled : 00:00)
- biospace.com/
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
12.94%
|
O:
-1.96%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-5.01%
|
O:
0.55%
H:
0.68%
C:
0.33%
QURE
|
$4.57
-3.79%
-3.94%
640K
|
Health Technology
|
-77.39%
|
O:
0.4%
H:
3.8%
C:
2.37%
RARE
F
|
$44.26
-1.88%
-1.92%
670K
|
Health Technology
|
4.16%
|
O:
0.92%
H:
3.17%
C:
1.0%
RGNX
|
$16.05
0.94%
0.93%
350K
|
Health Technology
|
-17.7%
|
O:
0.05%
H:
5.85%
C:
3.74%
financial
results
REGENXBIO Reports Third Quarter 2022 Financial Results and Recent Operational Highlights
Published:
2022-11-03
(Crawled : 12:20)
- biospace.com/
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
22.04%
|
O:
-0.82%
H:
0.83%
C:
0.56%
QURE
|
$4.57
-3.79%
-3.94%
640K
|
Health Technology
|
-77.44%
|
O:
-2.13%
H:
4.15%
C:
-0.56%
RARE
F
|
$44.26
-1.88%
-1.92%
670K
|
Health Technology
|
9.09%
|
O:
0.25%
H:
3.17%
C:
-6.19%
RCKT
4
|
$23.64
-0.13%
-0.13%
920K
|
Health Technology
|
30.62%
|
O:
-1.88%
H:
4.96%
C:
0.17%
RGNX
|
$16.05
0.94%
0.93%
350K
|
Health Technology
|
-33.83%
|
O:
-3.01%
H:
0.77%
C:
-10.46%
financial
results
Macular Degeneration Treatment Global Market to Reach $10.65 Billion by 2026 at a CAGR of 7.15%
Published:
2022-09-14
(Crawled : 10:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
29.11%
|
O:
-4.98%
H:
7.63%
C:
2.67%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
20.01%
|
O:
-0.55%
H:
0.42%
C:
-0.72%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
29.18%
|
O:
-0.6%
H:
0.41%
C:
-0.76%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
16.3%
|
O:
0.41%
H:
11.64%
C:
6.22%
RGNX
|
$16.05
0.94%
0.93%
350K
|
Health Technology
|
-39.08%
|
O:
0.38%
H:
2.53%
C:
1.48%
treatment
global
macular
market
Eyenovia Announces Appointments of Dr. Ellen Strahlman and Dr. Ram Palanki as New and Independent Members of its Board of Directors
Published:
2022-07-07
(Crawled : 16:00)
- biospace.com/
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-50.2%
|
O:
0.38%
H:
1.11%
C:
0.89%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
17.46%
|
O:
0.75%
H:
0.23%
C:
0.05%
BDX
|
$233.83
-0.23%
3.49%
780K
|
Health Technology
|
-5.06%
|
O:
-0.19%
H:
1.04%
C:
0.24%
MO
4
|
$42.92
0.12%
0.0%
12M
|
Consumer Non-Durables
|
4.28%
|
O:
0.75%
H:
1.24%
C:
0.82%
RGNX
|
$16.05
0.94%
0.93%
350K
|
Health Technology
|
-41.76%
|
O:
0.11%
H:
3.05%
C:
0.15%
EYEN
|
$0.5897
8.68%
7.99%
770K
|
Health Technology
|
-68.98%
|
O:
-2.14%
H:
4.92%
C:
4.92%
Global Macular Degeneration Treatment Market Report (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published:
2022-06-09
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
30.32%
|
O:
-1.02%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
12.59%
|
O:
0.49%
H:
0.47%
C:
-1.59%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
-4.89%
|
O:
-0.89%
H:
0.67%
C:
-6.05%
RGNX
|
$16.05
0.94%
0.93%
350K
|
Health Technology
|
-29.21%
|
O:
-0.75%
H:
0.53%
C:
-3.07%
treatment
report
macular
market
REGENXBIO Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Operational Highlights
Published:
2022-03-01
(Crawled : 22:00)
- biospace.com/
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
12.25%
|
O:
2.9%
H:
0.0%
C:
-1.59%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
13.03%
|
O:
1.3%
H:
0.0%
C:
0.0%
RARE
F
|
$44.26
-1.88%
-1.92%
670K
|
Health Technology
|
-34.22%
|
O:
-0.42%
H:
2.66%
C:
0.49%
RCKT
4
|
$23.64
-0.13%
-0.13%
920K
|
Health Technology
|
32.68%
|
O:
0.56%
H:
0.22%
C:
-6.92%
RGNX
|
$16.05
0.94%
0.93%
350K
|
Health Technology
|
-38.8%
|
O:
0.34%
H:
2.79%
C:
0.57%
financial results
report
results
Macular Degeneration Treatment Market size worth $ 11.98 Billion, Globally, by 2028 at 6.01% CAGR: Verified Market Research®
Published:
2022-02-14
(Crawled : 09:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
14.94%
|
O:
0.96%
H:
0.0%
C:
-0.81%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
-65.94%
|
O:
-0.48%
H:
1.52%
C:
-1.08%
RGNX
|
$16.05
0.94%
0.93%
350K
|
Health Technology
|
-36.1%
|
O:
0.92%
H:
0.87%
C:
-0.91%
research
treatment
macular
REGENXBIO Reports Third Quarter 2021 Financial Results and Operational Highlights
Published:
2021-11-02
(Crawled : 20:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
14.76%
|
O:
-0.7%
H:
0.82%
C:
0.82%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
17.43%
|
O:
-0.59%
H:
0.67%
C:
0.4%
SLDB
|
$8.75
-3.95%
-4.11%
140K
|
Health Technology
|
313.68%
|
O:
1.89%
H:
9.26%
C:
8.8%
RGNX
|
$16.05
0.94%
0.93%
350K
|
Health Technology
|
-56.16%
|
O:
4.62%
H:
1.4%
C:
-1.41%
financial results
results
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.